2型糖尿病患者在开始使用钠-葡萄糖协同转运蛋白2抑制剂3天后，同时采用极低碳水化合物饮食时发生正常血糖性糖尿病酮症酸中毒：一例报告
Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus 3 days after initiating sodium-glucose cotransporter 2 inhibitor while on an extremely low carbohydrate diet: A case report.
作者信息
Inoue Ayumi, Katayama Akihiro, Sue Mihiro, Hasegawa Momoka, Maeda Megumi, Matoba Masaki, Ishii Takahiro, Kuribayashi Remi, Tenta Masafumi, Matsushita Yuichi, Takeda Masaya, Iseda Izumi, Wakatsuki Toshiyuki, Hida Kazuyuki
机构信息
Department of Diabetology and Metabolism National Hospital Organization, Okayama Medical Center Okayama Japan.
Department of Gastroenterology National Hospital Organization, Okayama Medical Center Okayama Japan.
出版信息
Clin Case Rep. 2022 Nov 15;10(11):e6572. doi: 10.1002/ccr3.6572. eCollection 2022 Nov.
This paper presents a case with type 2 diabetes mellitus on a very-low-carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium-glucose cotransporter 2 inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of a low-carbohydrate diet and provide intensive guidance to prevent EDKA.
本文介绍了一例2型糖尿病患者，其采用极低碳水化合物饮食，在开始使用钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）3天后发生了正常血糖性糖尿病酮症酸中毒（EDKA）。在启动SGLT2i时，医疗保健提供者应确认低碳水化合物饮食的实施情况，并提供强化指导以预防EDKA。
Zotero 插件